Asset Search
Displaying all 5 assets.
-
Description Percentage of Participants Based on Age at Enrollment Reporting No Pimecrolimus Use in the Previous 6-Month Interval Since Enrollment
Article Title: Association Between Malignancy and Topical Use of Pimecrolimus
Publication Title: JAMA Dermatology -
Description Expected Surveillance, Epidemiology, and End Results Rates of Malignancy Standardized by Age to the Pediatric Eczema Elective Registry Populationa
Article Title: Association Between Malignancy and Topical Use of Pimecrolimus
Publication Title: JAMA Dermatology -
Description Reported Malignancies in the Pediatric Eczema Elective Registry Cohort
Article Title: Association Between Malignancy and Topical Use of Pimecrolimus
Publication Title: JAMA Dermatology -
Description Expected Surveillance, Epidemiology, and End Results Rates of Malignancy by Age Group and Diagnosis
Article Title: Association Between Malignancy and Topical Use of Pimecrolimus
Publication Title: JAMA Dermatology -
Description Accrued Person-years in the Pediatric Eczema Elective Registry Cohort Based on Age at the Time of Each 6-Month Survey Response
Article Title: Association Between Malignancy and Topical Use of Pimecrolimus
Publication Title: JAMA Dermatology
Displaying all 5 assets.